Literature DB >> 33446183

Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies.

Bradley J Vivace1,2, Allyson N Sanders3, Steven D Glassman4, Leah Y Carreon4, Joseph L Laratta4, Jeffrey L Gum4.   

Abstract

BACKGROUND: Recent work has shed light on the potential benefits of cannabinoids for multimodal pain control following orthopedic procedures. The objective of this review was to summarize the available evidence of analgesic and opioid-sparing effects cannabinoids have in orthopedic surgery and identify adverse events associated with their use.
METHODS: A systematic review of the literature using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines including PubMed, EMBASE, MEDLINE, PsycINFO, and Google Scholar was performed to include all primary, therapeutic studies published on the use of cannabis, and cannabis-derived products in orthopedic surgery.
RESULTS: The literature review returned 4292 citations. Thirteen publications were found to meet inclusion criteria. Four randomized controlled trials were evaluated while the remaining studies were of quasi-experimental design.
CONCLUSION: Research on cannabinoids in orthopedic surgery is mostly of a quasi-experimental nature and is mainly derived from studies where orthopedics was not the primary focus. The overall results demonstrate potential usefulness of cannabinoids as adjunctive analgesics and in mitigating opioid use. However, the current evidence is far from convincing. There is a need to produce rigorous evidence with well-designed randomized controlled trials specific to orthopedic surgery to further establish these effects.

Entities:  

Keywords:  Analgesia; Arthroplasty; Cannabinoids; Multimodal pain control; Opioids; Orthopedic surgery

Mesh:

Substances:

Year:  2021        PMID: 33446183      PMCID: PMC7809869          DOI: 10.1186/s13018-021-02205-y

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  50 in total

1.  RoB 2: a revised tool for assessing risk of bias in randomised trials.

Authors:  Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins
Journal:  BMJ       Date:  2019-08-28

Review 2.  How important are sex differences in cannabinoid action?

Authors:  Liana Fattore; Walter Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 3.  Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.

Authors:  R S Gable
Journal:  Am J Drug Alcohol Abuse       Date:  1993       Impact factor: 3.829

Review 4.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

5.  Preoperative Opiate Use Independently Predicts Narcotic Consumption and Complications After Total Joint Arthroplasty.

Authors:  Joshua C Rozell; Paul M Courtney; Jonathan R Dattilo; Chia H Wu; Gwo-Chin Lee
Journal:  J Arthroplasty       Date:  2017-04-12       Impact factor: 4.757

6.  Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.

Authors:  Yuyan Shi
Journal:  Drug Alcohol Depend       Date:  2017-02-21       Impact factor: 4.492

7.  Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).

Authors:  Mark A Ware; Tongtong Wang; Stan Shapiro; Jean-Paul Collet
Journal:  J Pain       Date:  2015-09-16       Impact factor: 5.820

8.  Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach.

Authors:  Dirk W Lachenmeier; Jürgen Rehm
Journal:  Sci Rep       Date:  2015-01-30       Impact factor: 4.379

9.  Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain.

Authors:  Epifanio Mondello; Domenico Quattrone; Luigi Cardia; Giuseppe Bova; Raffaella Mallamace; Alessia A Barbagallo; Cristina Mondello; Carmen Mannucci; Martina Di Pietro; Vincenzo Arcoraci; Gioacchino Calapai
Journal:  J Pain Res       Date:  2018-09-06       Impact factor: 3.133

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  1 in total

1.  Pain Management Strategies After Orthopaedic Trauma: A Mixed-Methods Study with a View to Optimizing Practices.

Authors:  Sonia Grzelak; Mélanie Bérubé; Marc-Aurèle Gagnon; Caroline Côté; Valérie Turcotte; Stéphane Pelet; Étienne Belzile
Journal:  J Pain Res       Date:  2022-02-09       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.